Skip to main content
Year archive

Bio Solution Co.,Ltd. — 2023 filings

All 22 regulatory filings released by Bio Solution Co.,Ltd. (086820) in 2023, sourced directly from the official regulator.

22 Filings
2023 Period
2023 filings (22)
Filing Released Lang
타법인주식및출자증권취득결정
M&A Activity
2023-12-21 Korean
기업설명회(IR)개최
Report Publication Announcement
2023-12-14 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2023-12-12 Korean
[기재정정]반기보고서 (2023.06)
Interim / Quarterly Report H1 2023
2023-11-22 Korean
분기보고서 (2023.09)
Interim / Quarterly Report 9M 2023
2023-11-14 Korean
소송등의제기ㆍ신청(경영권분쟁소송)(주주명부열람등사)
Legal Proceedings Report
2023-08-24 Korean
투자판단관련주요경영사항(임상시험계획승인신청)(펠렛형 동종 연골세포치료제(카티로이드)의 제1/2상 임상시험계획승인 신청)
Regulatory Filings
2023-08-14 Korean
반기보고서 (2023.06)
Interim / Quarterly Report H1 2023
2023-08-14 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Q1 2023
2023-05-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-04-11 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2023-03-29 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-03-29 Korean
감사보고서제출
Audit Report / Information FY 2022
2023-03-21 Korean
[기재정정]파생상품거래손실발생
Legal Proceedings Report
2023-03-21 Korean
사업보고서 (2022.12)
Annual Report FY 2022
2023-03-21 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2023-03-14 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2023-03-14 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2023-03-10 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-03-08 Korean
파생상품거래손실발생
Capital/Financing Update
2023-02-13 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2022
2023-02-10 Korean
배당락
Notice of Dividend Amount
2023-01-11 Korean